CTXR earnings: a positive outcome, +6.8%

On May 12, 2023, Citius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.8% in the window around the event. It had already run -21.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.